SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWarpaint London Regulatory News (W7L)

Share Price Information for Warpaint London (W7L)

Share Price is delayed by 15 minutes
Get Live Data
212.50    -2.50 (-1.16%)
Bid:
210.00
Ask:
215.00
Spread: 5.00 (2.381%)
Market Cap: £171.67m
W7L Live PriceLast checked at - London Stock Exchange

Intraday Warpaint London Share Chart

Trading Update

6 Feb 2025 07:00

RNS Number : 0875W
Warpaint London PLC
06 February 2025
 

6 February 2025

 

Warpaint London PLC

 

("Warpaint", the "Company" or the "Group")

 

Trading Update

 

Strong trading performance for the year ending 31 December 2024 and a positive start to 2025

 

Warpaint London plc (AIM: W7L; OTCQX: WPNTF), the specialist supplier of colour cosmetics and owner of the W7 and Technic brands is pleased to provide a trading update for the year ended 31 December 2024.

 

Revenue for the year ended 31 December 2024 is expected to be approximately £102 million (2023: £89.6 million) and profit before tax to be approximately £24 million (2023: £18.1 million).

 

The strong trading performance has continued into January 2025, with revenue approximately 15% ahead of January 2024, at an improved margin.

 

The Company expects to release its results for the year ended 31 December 2024 in late April 2025.

 

Commenting, Sam Bazini, Chief Executive Officer of Warpaint, said: "I am pleased with the Group's performance in 2024 and the strong start to 2025, despite ongoing consumer spending headwinds. It was also pleasing that improved margins were maintained throughout the year.

 

"We expect to see continued growth across the Group in 2025 and we look forward to completing the acquisition of Brand Architekts later this month and integrating the business into the Group."

 

Note: All figures used in this announcement, other than those in respect of the financial year ended 31 December 2023, remain subject to audit.

 

 

Enquiries:

 

Warpaint London

Sam Bazini - Chief Executive Officer

Eoin Macleod - Managing Director

Neil Rodol - Chief Financial Officer

 

c/o IFC

 

 

 

 

 

Shore Capital (Nominated Adviser & Broker)

Patrick Castle, Daniel Bush - Corporate Advisory

Fiona Conroy - Corporate Broking

 

020 7408 4090

 

IFC Advisory (Financial PR & IR)

Tim Metcalfe, Graham Herring, Florence Chandler

 

020 3934 6630

 

 

 

Warpaint London plc

 

Warpaint sells branded cosmetics under the lead brand names of W7 and Technic. W7 is sold in the UK primarily to major retailers and internationally to local distributors or retail chains. The Technic brand is sold in the UK and continental Europe with a significant focus on the gifting market, principally for high street retailers and supermarkets. In addition, Warpaint supplies cosmetics under its other brand names of Man'stuff, Body Collection and Chit Chat, each targeting a different demographic.

 

Appendix: Profit forecasts

 

Warpaint London plc Profit Estimate for FY 2024

 

 1.1. The guidance in relation to FY 2024 included in this announcement constitutes an ordinary course profit estimate ("FY 2024 Profit Estimate") for the purposes of the City Code on Takeovers and Mergers (the "Code"):

 

1.2. Basis of preparation

 

The basis of accounting used for the FY 2024 Profit Estimate is consistent with the Group's existing accounting policies, which are in accordance with UK-adopted International Accounting Standards and in accordance with the Companies Act 2006 and the accounting policies which were applied in the preparation of the Group's financial statements for the year ended 31 December 2023.

 

Although the financial period to which the FY 2024 Profit Estimate relates has been completed, the Company's audited accounts for the year ended 31 December 2024 are not available as at the date of this trading update. Accordingly, the FY 2024 Profit Estimate is based on the Company's unaudited interim results for the six months ended 30 June 2024 and the Company's unaudited management accounts for the six months ended 31 December 2024.

 

1.3. Principal assumptions

 

1.4. In confirming the FY 2024 Profit Estimate remains valid, the directors of Warpaint have made the following principal assumptions in respect of the financial year ending 31 December 2024:

 

Factors outside the influence or control of the Company

 

• there will be no retrospective change in legislation or regulatory requirements that will have a material impact on the Company's operations.

 

Factors both outside and within the influence or control of the Company

 

• no events will arise between the date of this trading update and the date on which the Company announces its audited results for the financial year ended 31 December 2024, which would require incorporation in the FY 2024 results in accordance with UK-adopted International Accounting Standards and/or the Company's accounting policies.

 

 

1.5. Directors' confirmation

 

The Directors confirm that the FY 2024 Profit Estimate remains valid and that it has been properly compiled on the basis of the principal assumptions stated above and that the basis of accounting used is consistent with Warpaint's accounting policies set out above.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTSSIFAIEISELE
Date   Source Headline
24th Mar 20237:00 amRNSTrading Update and Notice of Results
14th Feb 202310:16 amRNSAIM Rule 17 Notification
11th Jan 20237:00 amRNSFull Year Trading Update
3rd Jan 20237:00 amRNSResignation of Non-Executive Director
14th Oct 20227:00 amRNSRenewal of New Moorcroft House lease at Silsden
21st Sep 20227:00 amRNSInterim Results
16th Sep 20227:00 amRNSChange of Adviser
8th Sep 20224:40 pmRNSSecond Price Monitoring Extn
8th Sep 20224:36 pmRNSPrice Monitoring Extension
8th Sep 20222:06 pmRNSSecond Price Monitoring Extn
8th Sep 20222:00 pmRNSPrice Monitoring Extension
8th Sep 202211:05 amRNSSecond Price Monitoring Extn
8th Sep 202211:00 amRNSPrice Monitoring Extension
8th Sep 20227:00 amRNSTrading Update
1st Sep 20227:00 amRNSNotice of Results and Investor Webinar
29th Jun 20227:00 amRNSPMDR / PCA Dealing
28th Jun 20227:00 amRNSDirector/PDMR Dealing
27th Jun 202211:34 amRNSResult of AGM
27th Jun 20227:00 amRNSAGM Statement
31st May 20227:00 amRNSNotice of AGM and Posting of Annual Report
26th Apr 20223:57 pmRNSDividend Timetable
26th Apr 20227:00 amRNSResults for the year ended 31 December 2021
12th Apr 20227:00 amRNSTrading Update and Notice of Results
21st Mar 20221:21 pmRNSHolding(s) in Company
11th Mar 20225:23 pmRNSPMDR / PCA Dealing
2nd Mar 20227:00 amRNSWard & Hagon Contract Renewal and Grant of Options
28th Feb 20224:29 pmRNSHolding(s) in Company
23rd Feb 20224:56 pmRNSHolding(s) in Company
1st Feb 20227:00 amRNSFull Year Trading Update
2nd Nov 20217:00 amRNSTrading Update
22nd Sep 20217:00 amRNSInterim Results
16th Sep 202112:16 pmRNSPrice Monitoring Extension
14th Sep 20219:05 amRNSSecond Price Monitoring Extn
14th Sep 20219:00 amRNSPrice Monitoring Extension
1st Sep 20217:00 amRNSNotice of Results & Investor Webinar
3rd Aug 20217:00 amRNSAppointment of Non-Executive Director
11th Jun 202111:24 amRNSResult of AGM
11th Jun 202111:05 amRNSSecond Price Monitoring Extn
11th Jun 202111:00 amRNSPrice Monitoring Extension
11th Jun 20217:00 amRNSAGM Statement
28th May 202111:01 amRNSTotal Voting Rights
25th May 20213:28 pmRNSGrant of Options and Director/PDMR Shareholding
17th May 202112:34 pmRNSNotice of AGM and Posting of Annual Report
6th May 20213:57 pmRNSExercise of share options, issue of equity and TVR
28th Apr 20217:00 amRNSResults for the year ended 31 December 2020
20th Apr 20214:41 pmRNSSecond Price Monitoring Extn
20th Apr 20214:36 pmRNSPrice Monitoring Extension
20th Apr 20217:00 amRNSTrading Update and Notice of Results
19th Apr 20212:26 pmRNSHolding(s) in Company
8th Mar 20214:37 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.